Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
Effect of Obeticholic Acid (INT-747, Intercept) on the Hepatobiliary Transport of Bile Acids in Patients With PBC Examined by 11C-cholyl-sarcosine PET/CT
Sponsor: University of Aarhus
A EARLY_PHASE1 clinical study on Primary Biliary Cirrhosis, this trial is completed. The trial is conducted by University of Aarhus and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2019 — Jan 2021 [monthly]
Completed EARLY_PHASE1
Status: Unknown Status → Completed
-
Jun 2019 — Dec 2019 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .